426 related articles for article (PubMed ID: 24801414)
21. Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B.
Lee YB; Jung EU; Kim BH; Lee JH; Cho H; Ahn H; Choi WM; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Cho EJ; Yu SJ; Park SJ; Kim YJ; Park JW; Lee YJ; Kim CM; Yoon JH; Kim CY; Lee HS
Antimicrob Agents Chemother; 2015 Feb; 59(2):972-8. PubMed ID: 25421484
[TBL] [Abstract][Full Text] [Related]
22. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
van Bömmel F; Zöllner B; Sarrazin C; Spengler U; Hüppe D; Möller B; Feucht HH; Wiedenmann B; Berg T
Hepatology; 2006 Aug; 44(2):318-25. PubMed ID: 16871563
[TBL] [Abstract][Full Text] [Related]
23. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
[TBL] [Abstract][Full Text] [Related]
24. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
Wang M; Bian Q; Zhu Y; Pang Q; Chang L; Li R; Tiongson BC; Zhang H; Pan CQ
Aliment Pharmacol Ther; 2019 Jan; 49(2):211-217. PubMed ID: 30506691
[TBL] [Abstract][Full Text] [Related]
25. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
[TBL] [Abstract][Full Text] [Related]
26. Lamivudine plus tenofovir versus lamivudine plus adefovir for the treatment of hepatitis B virus in HIV-coinfected patients, starting antiretroviral therapy.
Sarkar J; Saha D; Bandyopadhyay B; Saha B; Chakravarty R; Guha SK
Indian J Med Microbiol; 2018; 36(2):217-223. PubMed ID: 30084414
[TBL] [Abstract][Full Text] [Related]
27. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.
Ahn SS; Chon YE; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH; Park JY
Clin Mol Hepatol; 2014 Sep; 20(3):261-6. PubMed ID: 25320729
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation.
Hakim GD; Akarsu M; Karademir S; Unek T; Astarcıoğlu İ
Turk J Gastroenterol; 2014 Dec; 25(6):685-9. PubMed ID: 25599782
[TBL] [Abstract][Full Text] [Related]
29. Role of tenofovir disoproxil fumarate in prevention of perinatal transmission of hepatitis B virus from mother to child: a systematic review and meta-analysis.
Lee YS; Lee HS; Kim JH; Chang SW; Hyun MH; Bak H; Kim S; Lee MJ; Lee CU; Jung YK; Seo YS; Yim HJ; Yeon JE; Um SH; Byun KS
Korean J Intern Med; 2021 Jan; 36(1):76-85. PubMed ID: 31878771
[TBL] [Abstract][Full Text] [Related]
30. Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate.
Lacombe K; Gozlan J; Boelle PY; Serfaty L; Zoulim F; Valleron AJ; Girard PM
AIDS; 2005 Jun; 19(9):907-15. PubMed ID: 15905671
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load.
Chen JZ; Liao ZW; Huang FL; Su RK; Wang WB; Cheng XY; Chen JQ; Liu JQ; Huang Z
Sci Rep; 2017 Jun; 7(1):4132. PubMed ID: 28646142
[TBL] [Abstract][Full Text] [Related]
32. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
33. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
[TBL] [Abstract][Full Text] [Related]
34. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
Jones J; Colquitt J; Shepherd J; Harris P; Cooper K
Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800
[TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
[TBL] [Abstract][Full Text] [Related]
36. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
38. Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women.
Tsai PJ; Chang A; Yamada S; Tsai N; Bartholomew ML
Dig Dis Sci; 2014 Nov; 59(11):2797-803. PubMed ID: 24898100
[TBL] [Abstract][Full Text] [Related]
39. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
Samadi Kochaksaraei G; Shaheen AA; Seow CH; Barkema HW; Coffin CS
Liver Int; 2022 Aug; 42(8):1712-1730. PubMed ID: 35312156
[TBL] [Abstract][Full Text] [Related]
40. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare.
Nguyen V; Tan PK; Greenup AJ; Glass A; Davison S; Samarasinghe D; Holdaway S; Strasser SI; Chatterjee U; Jackson K; Locarnini SA; Levy MT
Aliment Pharmacol Ther; 2014 May; 39(10):1225-34. PubMed ID: 24666381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]